Related Experiment Video
Updated: Feb 14, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension
Andrew King1,2, Mirjana Dimovska3, Luke Bisoski3
1Michigan Regional Poison Control Center, Wayne State University School of Medicine, Detroit, MI, USA. aking@dmc.org.
Purpose Of Review:
Acute drug-induced hypertension, sympathomimetic toxicity, and other hyperadrenergic states can be caused by both xenobiotic toxicity and withdrawal. This manuscript is a selective review of the recent literature regarding pharmacologic causes of hypertensive emergencies and other hyperadrenergic states.
Recent Findings:
We will discuss designer stimulants, alpha2 and baclofen agonist withdrawal, and the clinical entity known as posterior reversible encephalopathy syndrome (PRES). Additionally, we examine the controversial "unopposed alpha" phenomenon which may result from use of beta-adrenergic antagonist in the presence of stimulant toxicity. These topics encompass clinical situations and disease entities that are increasingly encountered and are often either unanticipated or under-recognized.
Related Concept Videos
Toxidromes: Clinical Features
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Hypertension and Regulation of Blood Pressure

